Probes and assays for measuring E3 ligase activity

US9951371B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9951371-B2
Application numberUS-201514856251-A
CountryUS
Kind codeB2
Filing dateSep 16, 2015
Priority dateSep 17, 2014
Publication dateApr 24, 2018
Grant dateApr 24, 2018

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Provided herein is technology relating to the biological process of protein ubiquitination and particularly, but not exclusively, to compositions and methods for studying protein ubiquitination and developing therapeutics to modulate protein ubiquitination.

First claim

Opening claim text (preview).

We claim: 1. A composition comprising a ubiquitin C-terminal thioester fluorophore. comprises a ubiquitin covalently attached to a fluorophore by a thioester. 2. The composition of claim 1 wherein the ubiquitin C-terminal thioester fluorophore comprises a ubiquitin covalently attached to a linker and a linker covalently attached to the fluorophore. 3. The composition of claim 1 wherein the fluorophore is Fluorescein, Rhodamine, BODIPY, Alexa Fluor 488, Oregon Green 488, or Alexa Fluor 594. 4. The composition of claim 2 wherein the linker is an alkyl, cycloalkyl, aryl, heteroaryl, heteroalkyl polymer, carbon nanotube, quantum dot, or nanoparticle. 5. The composition of claim 1 wherein the ubiquitin comprises amino acids 1-76 of the ubiquitin polypeptide (SEQ ID NO: 1). 6. The composition of claim 1 further comprising an E3 ligase. 7. The composition of claim 6 wherein the E3 ligase is NEDD4, NEDD4L, ITCH, WWP1, WWP2, SMURF1, SMURF2, NEDL1, NEDL2, E6AP, HECTD2, KIAA0614, TRIP12, G2E3, EDD, HACE1, HECTD1, UBE3B, UBE3C, KIAA0317, HUWE1, HECTD3, HERC1, HERC2, HERC3, HERC4, HERC5, HERC6, SopA, NleL, ARIH1, ARIH2, CUL9, ANKIB1, PARK2, RNF144A, RNF144B, RBCK1, RNF19A, RNF19B, RNF31, RNF216, RNF14, RNF217, or a NEL E3 ligase. 8. The composition of claim 6 further comprising free fluorophore. 9. The composition of claim 6 further comprising activated E3˜Ub thioester.

Assignees

Inventors

Classifications

  • with steric inhibition or signal modification, e.g. fluorescent quenching · CPC title

  • C12Q1/25Primary

    involving enzymes not classifiable in groups C12Q1/26 {- C12Q1/66} · CPC title

  • Ligases (6) · CPC title

  • Ubiquitin-protein ligase (6.3.2.19), i.e. ubiquitin-conjugating enzyme · CPC title

  • from mammals · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9951371B2 cover?
Provided herein is technology relating to the biological process of protein ubiquitination and particularly, but not exclusively, to compositions and methods for studying protein ubiquitination and developing therapeutics to modulate protein ubiquitination.
Who is the assignee on this patent?
Univ Northwestern
What technology area does this patent fall under?
Primary CPC classification C12Q1/25. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Apr 24 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).